We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Theorem Clinical Research Appoints Vice President of Global Regulatory Affairs

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Theorem Clinical Research Appoints Vice President of Global Regulatory Affairs"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:

Bollwage previously served as Director of Global Regulatory Science at Bristol-Myers Squibb and as Executive Director and Regulatory Counsel of Global Regulatory Intelligence at i3 Research.

"Brian brings a wealth of global regulatory leadership experience in both the CRO and pharmaceutical industries," stated Theorem Clinical Research Chief Executive Officer John Potthoff. "I am certain that he will excel in his new role."

Bollwage is a food and drug law expert with published articles in Regulatory Affairs Focus, PharmaVOICE and Applied Clinical Trials, among others. A graduate of Rutgers Law School, he currently serves as an associate professor of food and drug law at Temple University in Philadelphia. Bollwage also holds a Master of Business Administration, specializing in pharmaceutical/chemical studies, and a Master of Science.